1. Home
  2. VAL vs GRFS Comparison

VAL vs GRFS Comparison

Compare VAL & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valaris Limited

VAL

Valaris Limited

HOLD

Current Price

$92.73

Market Cap

6.3B

Sector

Energy

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$9.49

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VAL
GRFS
Founded
1975
1940
Country
Employees
5642
23800
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
6.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VAL
GRFS
Price
$92.73
$9.49
Analyst Decision
Hold
Hold
Analyst Count
5
2
Target Price
$54.80
$10.15
AVG Volume (30 Days)
2.4M
422.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
1.47%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$5.47
Revenue Next Year
N/A
$4.92
P/E Ratio
$16.22
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$27.15
$6.19
52 Week High
$96.40
$11.14

Technical Indicators

Market Signals
Indicator
VAL
GRFS
Relative Strength Index (RSI) 74.79 53.84
Support Level $57.78 $9.07
Resistance Level $96.40 $9.77
Average True Range (ATR) 5.09 0.23
MACD 2.71 0.02
Stochastic Oscillator 90.98 55.71

Price Performance

Historical Comparison
VAL
GRFS

About VAL Valaris Limited

Valaris Ltd is an offshore contract drilling company. The company provides offshore contract drilling services to the international oil and gas industry with operations in almost every offshore market across six continents. Its business consists of four operating segments: Floaters, which includes drillships and semisubmersible rigs; Jackups; ARO; and Other, which consists of management services on rigs owned by third parties. It generates the majority of its revenue from the Floaters segment.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: